Header Logo

Connection

Barry Maron to Cardiology

Back to Details
This is a "connection" page, showing publications Barry Maron has written about Cardiology.
Barry Maron
Connection Strength
8.831
Cardiology
  1. Maron MS, Rowin EJ, Maron BJ. The ESC Risk Score Is Less Reliable than ACC/AHA Risk Factors in Hypertrophic Cardiomyopathy: When Sensitivity Trumps Specificity. Can J Cardiol. 2019 12; 35(12):1626-1628.
    View in: PubMed
    Score: 0.565
  2. Maron BJ. Harvey Feigenbaum, MD, and the Creation of Clinical Echocardiography: A Conversation With Barry J. Maron, MD. Am J Cardiol. 2017 12 01; 120(11):2085-2099.
    View in: PubMed
    Score: 0.503
  3. Maron BJ, Harris KM, Thompson PD, Eichner ER, Steinberg MH. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e343-5.
    View in: PubMed
    Score: 0.439
  4. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2343-2349.
    View in: PubMed
    Score: 0.439
  5. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM, Cooper LT, Link MS, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2362-2371.
    View in: PubMed
    Score: 0.439
  6. Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2356-2361.
    View in: PubMed
    Score: 0.439
  7. Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2424-2428.
    View in: PubMed
    Score: 0.439
  8. Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2398-2405.
    View in: PubMed
    Score: 0.439
  9. Maron BJ, Harris KM, Thompson PD, Eichner ER, Steinberg MH. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2444-2446.
    View in: PubMed
    Score: 0.439
  10. Link MS, Estes NAM, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2439-2443.
    View in: PubMed
    Score: 0.439
  11. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA, Cooper LT, Link MS, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e273-80.
    View in: PubMed
    Score: 0.439
  12. Harris KM, Katsiyiannis WT, Maron BJ. What Constitutes an "Academic" Cardiology Practice? There Are New Models to Consider. Am J Cardiol. 2015 Sep 15; 116(6):995-6.
    View in: PubMed
    Score: 0.430
  13. Maron BJ, Casey SA, Chan RH, Garberich RF, Rowin EJ, Maron MS. Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Sep 01; 116(5):757-64.
    View in: PubMed
    Score: 0.427
  14. Maron BJ. Importance and feasibility of creating hypertrophic cardiomyopathy centers in developing countries: the experience in India. Am J Cardiol. 2015 Jul 15; 116(2):332-4.
    View in: PubMed
    Score: 0.423
  15. Maron BJ, Rakowski H. Dr. Douglas E. Wigle. Am J Cardiol. 2015 Feb 15; 115(4):553.
    View in: PubMed
    Score: 0.418
  16. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Reply: Obstructive sleep apnea and hypertrophic cardiomyopathy: obiter dictum or more? J Am Coll Cardiol. 2014 Dec 16; 64(23):2562.
    View in: PubMed
    Score: 0.413
  17. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014 Jul 08; 64(1):83-99.
    View in: PubMed
    Score: 0.401
  18. Braunwald E, Maron BJ. Eugene Braunwald, MD and the early years of hypertrophic cardiomyopathy: a conversation with Dr. Barry J. Maron. Am J Cardiol. 2012 Jun 01; 109(11):1539-47.
    View in: PubMed
    Score: 0.341
  19. Maron BJ. Hypertrophic cardiomyopathy centers. Am J Cardiol. 2009 Oct 15; 104(8):1158-9.
    View in: PubMed
    Score: 0.286
  20. Maron BJ, Roberts WC. Barry Joel Maron, MD: a conversation with the Editor. Interview by William Clifford Roberts. Am J Cardiol. 2007 May 01; 99(9):1334-49.
    View in: PubMed
    Score: 0.242
  21. Mitten MJ, Zipes DP, Maron BJ, Bryant WJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2447-2450.
    View in: PubMed
    Score: 0.110
  22. Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e303-9.
    View in: PubMed
    Score: 0.110
  23. Link MS, Estes NA, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e339-42.
    View in: PubMed
    Score: 0.110
  24. Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD. Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2014 Oct 07; 64(14):1479-514.
    View in: PubMed
    Score: 0.101
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.